-
MEHP, AhR, and Ovarian Follicle Toxicity
2026-08-21
This 2024 study shows that mono(2-ethylhexyl) phthalate (MEHP) activates the aryl hydrocarbon receptor (AHR) in mouse ovarian antral follicles, linking receptor signaling to impaired follicle growth and estrogen production. Pharmacological blockade with CH 223191 partially or fully mitigated several endpoints, providing mechanistic support for AHR involvement in phthalate-related ovarian toxicity.
-
7ACC2: A Monocarboxylate Transporter 1 Inhibitor
2026-08-20
7ACC2 combines nanomolar lactate uptake inhibition with interference in mitochondrial pyruvate transport, enabling more informative cancer metabolism research than a single-pathway assay. This guide shows how to connect tumor-cell flux measurements with radiosensitization and tumor-associated macrophage studies while keeping direct evidence separate from testable hypotheses.
-
β-Elemene Assay Reliability: Practical Q&A
2026-08-20
This scenario-based guide explains how β-Elemene (SKU C5505) can be incorporated into cell viability, adipogenesis, cytotoxicity, and mechanism-focused assays. It covers solvent control, dose selection, orthogonal readouts, interpretation limits, and practical supplier-selection criteria supported by product specifications and a recent 3T3-L1 study.
-
3-Hydroxybutyrate (BHBA): From Ketosis to Cell Fate
2026-08-19
3-Hydroxybutyrate (BHBA) is more than a fuel: it connects ketone body signaling, ferroptosis control, membrane biology, and chromatin regulation. This article presents an assay-centered framework for distinguishing these mechanisms and translating ketosis research into reproducible experiments.
-
Exemestane for Reproducible Aromatase Assays
2026-08-19
This scenario-driven guide explains how Exemestane (SKU A1296) can support controlled estrogen biosynthesis inhibition in cell viability, proliferation, and hormone-dependent cancer assays. It connects mechanism, formulation, protocol design, data interpretation, and practical supplier selection to improve experimental clarity.
-
Asunaprevir (BMS-650032) HCV Workflows
2026-08-18
Asunaprevir (BMS-650032) supports mechanism-led studies that connect NS3/4A protease inhibition with HCV RNA replication inhibition across genotype-aware cellular models. This practical guide covers stock preparation, orthogonal readouts, assay controls, troubleshooting, and how a cross-domain screening framework can improve antiviral assay design.
-
Protease Inhibitor Cocktail: Assay Reliability
2026-08-18
A scenario-based guide to using Protease Inhibitor Cocktail (100X in DMSO, EDTA plus), SKU K1019, when viability, proliferation, or cytotoxicity studies require reliable protein readouts. It explains formulation, compatibility, workflow controls, interpretation, and practical vendor-selection criteria.
-
TET2 Metabolite Binding: A Practical STD NMR Protocol
2026-08-17
Zhang, Cheng, and Ye present an integrated workflow that combines biochemical activity assays with saturation transfer difference NMR to distinguish TET2-binding metabolites from compounds that functionally regulate the enzyme. The protocol validates known TET2 activators and inhibitors while providing a practical route for discovering additional metabolic regulators, including glyoxylate.
-
Catalpol in Osteoporosis: Sirt6–ERα–FasL Axis
2026-08-17
The reference study identifies a mechanistic route by which Catalpol, also known as Catalpinoside, protects against estrogen deficiency–associated bone loss: activation of the Sirt6–ERα–FasL axis promotes osteoclast apoptosis. Its combination of an ovariectomized rat osteoporosis animal model, osteoclast assays, protein analysis, and Sirt6 knockdown provides stronger mechanistic evidence than a bone-density observation alone.
-
Silymarin Workflows for Reproducible Cell Assays
2026-08-16
Build more reliable oxidative-stress, liver-cancer, metabolic, and antiviral experiments with a mixture-aware Silymarin workflow. The guide connects solvent control, dose-ranging, orthogonal readouts, and the structural chemistry of milk thistle extract to practical troubleshooting decisions.
-
Y-27632: ROCK Inhibitor Workflows for Fibroblasts
2026-08-15
Y-27632 provides a reversible, selective way to test how ROCK-dependent contractility shapes fibroblast architecture, stress fibers, and repair-associated phenotypes. This guide translates airway-repair findings into practical dosing, imaging, single-cell, and troubleshooting workflows while distinguishing established product parameters from assay-specific recommendations.
-
Pregnenolone Carbonitrile: PXR Workflow Guide
2026-08-14
Pregnenolone Carbonitrile is a practical rodent PXR probe for connecting receptor activation with CYP3A induction, xenobiotic clearance, antifibrotic phenotypes, and urine concentration. This workflow guide shows how to prepare PCN, build mechanistic controls, and troubleshoot results across liver, stellate-cell, and hypothalamic-kidney assays.
-
SERCA-ER Stress in HSC Mobilization
2026-08-14
Li et al. show that inhibiting SERCA with BHQ promotes hematopoietic stem cell mobilization by linking endoplasmic reticulum stress to the CaMKII-STAT3-CXCR4 axis. The study provides a mechanistic basis for investigating mild calcium homeostasis disruption as an adjunct strategy for improving hematopoietic stem cell collection.
-
Danazol in Endocrine Model Design: Receptor to Axis
2026-08-13
Explore how Danazol and Danocrine-related research materials can be used to connect androgen receptor pharmacology with hypothalamic–pituitary–gonadal axis models. This evidence-focused guide emphasizes model selection, endpoint interpretation, formulation, and translational limits.
-
Light-Inducible RNA Control for Gene Therapy
2026-08-13
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic gene expression at the level of translation. In mouse models, LIRP-regulated AAV systems enabled light-dependent intervention in metabolic disease and adjustable VEGF inhibition for retinal neovascularization, highlighting a potential safety advantage for on-demand gene therapy.